Daw NC - Search Results

1

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM. Carr S, et al. Among authors: daw nc. J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23. J Infect Dis. 2011. PMID: 21949042 Clinical Trial.

2

Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.

Rodriguez-Galindo C, Poquette CA, Daw NC, Tan M, Meyer WH, Cleveland JL. Rodriguez-Galindo C, et al. Among authors: daw nc. Med Pediatr Oncol. 2001 Jun;36(6):605-11. doi: 10.1002/mpo.1137. Med Pediatr Oncol. 2001. PMID: 11344491

3

Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.

Rodríguez-Galindo C, Daw NC, Kaste SC, Meyer WH, Dome JS, Pappo AS, Rao BN, Pratt CB. Rodríguez-Galindo C, et al. Among authors: daw nc. J Pediatr Hematol Oncol. 2002 May;24(4):250-5. doi: 10.1097/00043426-200205000-00006. J Pediatr Hematol Oncol. 2002. PMID: 11972091

4

High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.

Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC. Crews KR, et al. Among authors: daw nc. Cancer. 2004 Apr 15;100(8):1724-33. doi: 10.1002/cncr.20152. Cancer. 2004. PMID: 15073863 Free article. Clinical Trial.

5

Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).

Rodriguez-Galindo C, Shah N, McCarville MB, Billups CA, Neel MN, Rao BN, Daw NC. Rodriguez-Galindo C, et al. Among authors: daw nc. Cancer. 2004 May 1;100(9):1928-35. doi: 10.1002/cncr.20214. Cancer. 2004. PMID: 15112274 Free article.

6

The incidence and prognosis of osteosarcoma skip metastases.

Sajadi KR, Heck RK, Neel MD, Rao BN, Daw N, Rodriguez-Galindo C, Hoffer FA, Stacy GS, Peabody TD, Simon MA. Sajadi KR, et al. Clin Orthop Relat Res. 2004 Sep;(426):92-6. doi: 10.1097/01.blo.0000141493.52166.69. Clin Orthop Relat Res. 2004. PMID: 15346057

7

Effect of fractionated ifosfamide on the pharmacokinetics of irinotecan in pediatric patients with osteosarcoma.

Crews KR, Stewart CF, Liu T, Rodriguez-Galindo C, Santana VM, Daw NC. Crews KR, et al. Among authors: daw nc. J Pediatr Hematol Oncol. 2004 Nov;26(11):764-7. doi: 10.1097/00043426-200411000-00016. J Pediatr Hematol Oncol. 2004. PMID: 15543015 Clinical Trial.

8

Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experience.

Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Saab R, et al. Among authors: daw nc. Cancer. 2005 Apr 1;103(7):1468-74. doi: 10.1002/cncr.20959. Cancer. 2005. PMID: 15739209 Free article.

9

Infections in children and young adults with bone malignancies undergoing limb-sparing surgery.

Gaur AH, Liu T, Knapp KM, Daw NC, Rao BN, Neel MD, Rodriguez-Galindo C, Brand D, Adderson EE. Gaur AH, et al. Among authors: daw nc. Cancer. 2005 Aug 1;104(3):602-10. doi: 10.1002/cncr.21212. Cancer. 2005. PMID: 15952202 Free article.

10

Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors.

Rodriguez-Galindo C, Crews KR, Stewart CF, Furman W, Panetta JC, Daw NC, Cain A, Tan M, Houghton PH, Santana VM. Rodriguez-Galindo C, et al. Among authors: daw nc. Cancer Chemother Pharmacol. 2006 Jan;57(1):15-24. doi: 10.1007/s00280-005-0030-7. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001174 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page